Meridian Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Meridian Wealth Management's DGX Position: Q2 2026 in Review
Meridian Wealth Management reduced its Quest Diagnostics (DGX) stake by 0.12% in Q2 2026, selling an estimated $785 and leaving 3,348 shares worth $710K. The position accounts for 0.02% of the portfolio, ranked #462.
Meridian Wealth Management first reported a position in DGX in Q3 2020 and has held it in 23 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Meridian Wealth Management held 3,348 shares of Quest Diagnostics worth $710K as of Q2 2026.
- Meridian Wealth Management sold 4 Quest Diagnostics shares in Q2 2026, an estimated $785.
- Quest Diagnostics made up 0.02% of Meridian Wealth Management's portfolio in Q2 2026, its #462 holding.
- Meridian Wealth Management first reported a position in Quest Diagnostics in Q3 2020 and has held it in 23 quarters since.
- 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Meridian Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.